0001415889-11-001117.txt : 20111014
0001415889-11-001117.hdr.sgml : 20111014
20111014142251
ACCESSION NUMBER: 0001415889-11-001117
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111013
FILED AS OF DATE: 20111014
DATE AS OF CHANGE: 20111014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BURKE KIMBERLY A
CENTRAL INDEX KEY: 0001532658
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 111141567
MAIL ADDRESS:
STREET 1: ECHO THERAPEUTICS, INC.
STREET 2: 8 PENN CENTER, 1628 JFK BLVD., STE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Echo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001031927
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411649949
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-717-4100
MAIL ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020702
FORMER COMPANY:
FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/
DATE OF NAME CHANGE: 20020701
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020701
3
1
form3-10142011_111041.xml
X0204
3
2011-10-13
0
0001031927
Echo Therapeutics, Inc.
ECTE
0001532658
BURKE KIMBERLY A
8 PENN CENTER
1628 JFK BLVD, SUITE 300
PHILADELPHIA
PA
19103
false
true
false
false
General Counsel
Common Stock
175000
D
Nonqualified Stock Option (Right to Buy)
0.40
2017-10-23
Common Stock
35000
D
Incentive Stock Option (Right to Buy)
0.40
2018-06-30
Common Stock
65000
D
Incentive Stock Option (Right to Buy)
0.40
2019-01-08
Common Stock
45000
D
The restricted shares shall vest upon the first to occur of (i) FDA approval of the Company's Symphony tCGM System; or (ii) the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for liquid proceeds, which was defined as (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days; or (d) or a combination of cash and the foregoing securities.
The shares underlying this option fully vested on October 23, 2009.
The shares underlying this option fully vested on June 30, 2010.
The shares underlying this option fully vested on January 8, 2011.
/s/ Kimberly A. Burke
2011-10-14